XERS: Prakiraan wutah bathi saben saham kanggo taun ngarep xerispharma.com

Logo perusahaan publik Xeris Biopharma (XERS)

Xeris Biopharma revenues rely on an ecosystem of ready-to-use glucagon injectable forms, where loyalty is driven by the convenience of pre-filled pens. The projected net profit growth rate for n+1 visualizes expert expectations, while the 2425.50 metric confirms the current level. Stable formulations guarantee a predictable cash flow, and the development of neurology and endocrinology drugs effectively diversifies market risks.

Xeris Biopharma Holdings, Inc. (XERS): Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 17.11.2026

Rincian analitis lan laporan data perusahaan Xeris Biopharma Holdings, Inc. (XERS)

Pambiji fundamental perusahaan:XERS, xerispharma.com
Produk dadi Xeris Biopharma Holdings

To minimize risks when building a position, it is critical to track the dynamics of analysts' financial model revisions, where the projected net profit growth rate for n+1 reflects the real-time adjustment of EPS expectations. Given the outsourced production model of Xeris Biopharma (XERS), this metric confirms the effectiveness of SLA agreements, demonstrating how stable operating expenses translate into sustainable profit growth.

Analisis perusahaan pesaing

VRTX (Vertex) - Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep ALNY (Alnylam)|Prakiraan wutah bathi saben saham kanggo taun ngarep INSM (Insmed)|UTHR (United Therapeutics Corp) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|BGM Group Ltd - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep COGT (Cogent Biosciences)|KROS: Prakiraan wutah bathi kanggo taun ngarep|Arcturus Therapeutics Inc (ARCT) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Eton Pharma|KMDA: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep fulcrumtx.com (FULC)|Prakiraan wutah bathi saben saham kanggo taun ngarep Abeona Therapeutics Inc. ABEO|Prakiraan wutah bathi kanggo taun ngarep MREO (Mereo BioPharma Group)|PLX (Protalix BioTherapeutics Inc.) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|PLRX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|APLT - Prakiraan wutah bathi kanggo taun ngarep|RNTX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Gelteq Limited Inc (GELS)|Prakiraan wutah bathi saben saham kanggo taun ngarep AYTU|Prakiraan wutah bathi resik saben saham ing taun ngarep chemomab.com CMMB|Prakiraan wutah bathi saben saham kanggo taun ngarep SRXH (SRx Health Solutions Inc)|PLRZ - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Prakiraan wutah bathi resik saben saham ing taun ngarep|INZY - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep